glp-1 obesity drugs updates today FDA-approved semaglutide drug is the first pill for weight loss available in the U.S., according to drugmaker Novo Nordisk The next phase of the
Description
Slightly lower rates were seen with the lower dose 0.75 mg dulaglutide arm

doi: 10.1210/en.2005-0396

(September 2022)

Table 2 Main effect

Nogueiras R, Nauck MA, Tschop MH
All kidney injury cases were associated with severe dehydration from vomiting or diarrhea
